Global and Japan Synthetic Lethality-based Drugs and Targets Market Size, Status and Forecast 2021-2027

Global and Japan Synthetic Lethality-based Drugs and Targets Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Medical Research Institution
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Synthetic Lethality-based Drugs and Targets Market Perspective (2016-2027)
2.2 Synthetic Lethality-based Drugs and Targets Growth Trends by Regions
2.2.1 Synthetic Lethality-based Drugs and Targets Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Synthetic Lethality-based Drugs and Targets Historic Market Share by Regions (2016-2021)
2.2.3 Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Regions (2022-2027)
2.3 Synthetic Lethality-based Drugs and Targets Industry Dynamic
2.3.1 Synthetic Lethality-based Drugs and Targets Market Trends
2.3.2 Synthetic Lethality-based Drugs and Targets Market Drivers
2.3.3 Synthetic Lethality-based Drugs and Targets Market Challenges
2.3.4 Synthetic Lethality-based Drugs and Targets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue
3.1.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue (2016-2021)
3.1.2 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Players (2016-2021)
3.2 Global Synthetic Lethality-based Drugs and Targets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Synthetic Lethality-based Drugs and Targets Revenue
3.4 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio
3.4.1 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Synthetic Lethality-based Drugs and Targets Revenue in 2020
3.5 Synthetic Lethality-based Drugs and Targets Key Players Head office and Area Served
3.6 Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service
3.7 Date of Enter into Synthetic Lethality-based Drugs and Targets Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Synthetic Lethality-based Drugs and Targets Breakdown Data by Type
4.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Type (2016-2021)
4.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2022-2027)
5 Synthetic Lethality-based Drugs and Targets Breakdown Data by Application
5.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Application (2016-2021)
5.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
6.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Type
6.2.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
6.2.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
6.2.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
6.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Application
6.3.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
6.3.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
6.3.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
6.4 North America Synthetic Lethality-based Drugs and Targets Market Size by Country
6.4.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
6.4.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
7.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type
7.2.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
7.2.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
7.2.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
7.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application
7.3.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
7.3.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
7.3.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
7.4 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country
7.4.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
7.4.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
8.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type
8.2.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
8.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application
8.3.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
8.4 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region
8.4.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
9.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type
9.2.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
9.2.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
9.2.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
9.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application
9.3.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
9.3.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
9.3.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
9.4 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country
9.4.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
9.4.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size (2016-2027)
10.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type
10.2.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2027)
10.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application
10.3.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2027)
10.4 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country
10.4.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Introduction
11.1.4 AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Introduction
11.2.4 AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 BeiGene
11.3.1 BeiGene Company Details
11.3.2 BeiGene Business Overview
11.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Introduction
11.3.4 BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.3.5 BeiGene Recent Development
11.4 Clovis Oncology
11.4.1 Clovis Oncology Company Details
11.4.2 Clovis Oncology Business Overview
11.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Introduction
11.4.4 Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.4.5 Clovis Oncology Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Introduction
11.5.4 GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Introduction
11.6.4 Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 AtlasMedx
11.7.1 AtlasMedx Company Details
11.7.2 AtlasMedx Business Overview
11.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Introduction
11.7.4 AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.7.5 AtlasMedx Recent Development
11.8 Chordia Therapeutics
11.8.1 Chordia Therapeutics Company Details
11.8.2 Chordia Therapeutics Business Overview
11.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.8.4 Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.8.5 Chordia Therapeutics Recent Development
11.9 IDEAYA Biosciences
11.9.1 IDEAYA Biosciences Company Details
11.9.2 IDEAYA Biosciences Business Overview
11.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Introduction
11.9.4 IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.9.5 IDEAYA Biosciences Recent Development
11.10 Mission Therapeutics
11.10.1 Mission Therapeutics Company Details
11.10.2 Mission Therapeutics Business Overview
11.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.10.4 Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.10.5 Mission Therapeutics Recent Development
11.11 Repare Therapeutics
11.11.1 Repare Therapeutics Company Details
11.11.2 Repare Therapeutics Business Overview
11.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.11.4 Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.11.5 Repare Therapeutics Recent Development
11.12 Sierra Oncology
11.12.1 Sierra Oncology Company Details
11.12.2 Sierra Oncology Business Overview
11.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Introduction
11.12.4 Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.12.5 Sierra Oncology Recent Development
11.13 SyntheX Labs
11.13.1 SyntheX Labs Company Details
11.13.2 SyntheX Labs Business Overview
11.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Introduction
11.13.4 SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
11.13.5 SyntheX Labs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global Synthetic Lethality-based Drugs and Targets Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Synthetic Lethality-based Drugs and Targets Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Synthetic Lethality-based Drugs and Targets Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2016-2021)
Table 8. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2022-2027)
Table 10. Synthetic Lethality-based Drugs and Targets Market Trends
Table 11. Synthetic Lethality-based Drugs and Targets Market Drivers
Table 12. Synthetic Lethality-based Drugs and Targets Market Challenges
Table 13. Synthetic Lethality-based Drugs and Targets Market Restraints
Table 14. Global Synthetic Lethality-based Drugs and Targets Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Synthetic Lethality-based Drugs and Targets Market Share by Players (2016-2021)
Table 16. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2020)
Table 17. Ranking of Global Top Synthetic Lethality-based Drugs and Targets Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service
Table 21. Date of Enter into Synthetic Lethality-based Drugs and Targets Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2016-2021)
Table 25. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Synthetic Lethality-based Drugs and Targets Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2016-2021)
Table 29. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Synthetic Lethality-based Drugs and Targets Product
Table 64. AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. AstraZeneca Company Details
Table 67. AstraZeneca Business Overview
Table 68. AstraZeneca Synthetic Lethality-based Drugs and Targets Product
Table 69. AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 70. AstraZeneca Recent Development
Table 71. BeiGene Company Details
Table 72. BeiGene Business Overview
Table 73. BeiGene Synthetic Lethality-based Drugs and Targets Product
Table 74. BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 75. BeiGene Recent Development
Table 76. Clovis Oncology Company Details
Table 77. Clovis Oncology Business Overview
Table 78. Clovis Oncology Synthetic Lethality-based Drugs and Targets Product
Table 79. Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 80. Clovis Oncology Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product
Table 84. GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Synthetic Lethality-based Drugs and Targets Product
Table 89. Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. AtlasMedx Company Details
Table 92. AtlasMedx Business Overview
Table 93. AtlasMedx Synthetic Lethality-based Drugs and Targets Product
Table 94. AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 95. AtlasMedx Recent Development
Table 96. Chordia Therapeutics Company Details
Table 97. Chordia Therapeutics Business Overview
Table 98. Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 99. Chordia Therapeutics Recent Development
Table 100. IDEAYA Biosciences Company Details
Table 101. IDEAYA Biosciences Business Overview
Table 102. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product
Table 103. IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 104. IDEAYA Biosciences Recent Development
Table 105. Mission Therapeutics Company Details
Table 106. Mission Therapeutics Business Overview
Table 107. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product
Table 108. Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 109. Mission Therapeutics Recent Development
Table 110. Repare Therapeutics Company Details
Table 111. Repare Therapeutics Business Overview
Table 112. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product
Table 113. Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 114. Repare Therapeutics Recent Development
Table 115. Sierra Oncology Company Details
Table 116. Sierra Oncology Business Overview
Table 117. Sierra Oncology Synthetic Lethality-based Drugs and Targets Product
Table 118. Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 119. Sierra Oncology Recent Development
Table 120. SyntheX Labs Company Details
Table 121. SyntheX Labs Business Overview
Table 122. SyntheX Labs Synthetic Lethality-based Drugs and Targets Product
Table 123. SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2016-2021) & (US$ Million)
Table 124. SyntheX Labs Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Synthetic Lethality-based Drugs and Targets Market Share by Type: 2020 VS 2027
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2020 VS 2027
Figure 5. Medical Research Institution Case Studies
Figure 6. Hospital and Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Synthetic Lethality-based Drugs and Targets Report Years Considered
Figure 9. Global Synthetic Lethality-based Drugs and Targets Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Synthetic Lethality-based Drugs and Targets Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions: 2020 VS 2027
Figure 12. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2022-2027)
Figure 13. Global Synthetic Lethality-based Drugs and Targets Market Share by Players in 2020
Figure 14. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue in 2020
Figure 16. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2016-2021)
Figure 17. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2022-2027)
Figure 18. North America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 20. North America Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 21. North America Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
Figure 22. United States Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 26. Europe Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 27. Europe Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
Figure 28. Germany Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Region (2016-2027)
Figure 38. China Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 46. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 47. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
Figure 48. Mexico Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Country (2016-2027)
Figure 54. Turkey Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AbbVie Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 58. AstraZeneca Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2016-2021)
Figure 59. BeiGene Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Busine

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs